Nippon Life Insurance Co. Japan's largest life insurer, is weighing increased holdings of government bonds in the upcoming fiscal year—a reversal from its 2022 pivot away from sovereign debt as rising rates eroded valuations.
Daisuke Ishida, the company's executive overseeing finance and investment planning, said boosting JGB exposure "is entirely possible," with the insurer targeting replacement trades to lock in higher yields. "We want to firmly capture the current high yields through replacement," Ishida said. "We will not halt replacement based solely on market outlook."
The move reflects a critical shift in institutional calculus: the Bank of Japan's ongoing tightening cycle—with rates potentially reaching 1.5 percent in coming years—has made the 10-year JGB yield competitive again after years of suppression under ultra-loose policy. For an insurer holding a significant book of sub-1 percent bonds, duration extension at current levels offers material spread capture.
Nippon Life's conditions for renewed buying hinge on two variables: inflation stabilization and rate volatility. "If we determine that the probability of a risk scenario involving rising interest rates has decreased, we may judge that this is a good time to buy bonds," Ishida said. Geopolitical shocks—he cited Middle East tensions as a potential catalyst for sudden rate spikes—could accelerate portfolio adjustments.
Nippon Life is not alone. Meiji Yasuda announced in July that it would double government bond purchases to more than 2 trillion yen this year. Daiichi Life Group has directly engaged companies to explore corporate bond issuance, signaling broader institutional demand for yield in a market starved of it for nearly a decade.
The shift matters for JGB market structure. After years of BOJ yield-curve control and suppressed yields, institutional re-engagement from domestic life insurers—traditionally the marginal buyers of long duration—could stabilize the long end as the central bank continues gradual policy normalization.
